drugset / Trial / NCT03392961

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

NCT03392961

Phase 1 Completed 51 enrolled Biocon Limited
RandomizedCrossoverOpen-labelTreatment

Summary

A study to evaluate the PK and PD of oral IN-105 (Insulin Tregopil) w.r.t. time of dosing prior to meal, duration between meals and type of meal .

Timeline

Start
2014-03-27
Primary completion
2014-07-01
Completion
2014-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Tregopil Protein / enzyme biologic 30 mg Oral